Broad consent is a type of permission that allows researchers to store and reuse your biological samples or personal health information for future studies that haven’t been designed yet. It was formally introduced into U.S. research regulations in 2018 as part of the revised Common Rule, the federal policy governing human subjects research. Unlike traditional informed consent, where you agree to one specific study with defined goals, broad consent covers a potentially open-ended range of future research uses.
How Broad Consent Differs From Standard Consent
In a typical research study, you receive a detailed explanation of what researchers plan to do, what risks are involved, and what they hope to learn. You agree to that particular project. If a different team later wants to use your leftover blood sample or medical data for an unrelated study, they would normally need to come back and ask your permission again.
Broad consent eliminates that back-and-forth. When you sign a broad consent form, you’re agreeing upfront that your identifiable private information or biospecimens (things like tissue samples, blood draws, or genetic material) can be stored and used in secondary research down the line. The revised Common Rule specifically permits broad consent “in lieu of informed consent” for the storage, maintenance, and secondary research uses of identifiable private information and identifiable biospecimens. In practice, this means a hospital could collect a tissue sample during surgery, and with your broad consent, that sample could later be used in cancer research, genetic studies, or other projects you may never hear about individually.
What Counts as Identifiable Information
Broad consent applies specifically to information or samples that can be linked back to you. Under federal rules, “identifiable private information” means data where your identity is or could readily be figured out by the researcher. This includes medical records, behavioral data collected in private settings, and anything you provided expecting it to stay confidential. An “identifiable biospecimen” follows the same logic: if a tissue or blood sample is tagged with your name, medical record number, or another identifier that a researcher could trace back to you, it qualifies.
If samples or data are fully stripped of identifying details so that no one could reconnect them to you, they generally fall outside the scope of broad consent requirements altogether. The consent question becomes most important in the gray area where researchers want to keep identifiers attached, often because linking samples to medical histories makes the research far more valuable.
Where Broad Consent Gets Used
Biobanks are the most common setting for broad consent. These are large repositories that collect and store biological samples, often alongside associated health data, for use by many different research teams over time. The Texas Cancer Research Biobank, for example, developed its consent process using what it describes as “a broad, forward-looking approach to maximize the utility of the specimens and associated data and minimize the need for reconsent in the future.” Many hospital-based biobanks and large genomic research programs follow a similar model.
The practical appeal is straightforward. Recontacting thousands of people every time a new study wants to analyze stored samples is expensive, time-consuming, and sometimes impossible if participants have moved or died. Broad consent keeps the pipeline open for research without requiring repeated contact.
What Happens If You Change Your Mind
You can withdraw broad consent, but the practical effects depend on timing and what was promised in the original consent form. Federal guidance clarifies that if you withdraw consent, researchers may continue using your data and samples as long as they’ve been stripped of identifiers, making them no longer subject to consent requirements. However, if the consent form explicitly promised that withdrawal would stop all future use of your materials, even in de-identified form, that promise must be honored.
There are limits to what withdrawal can undo. If a study using your identifiable data or samples is already underway when you withdraw, researchers can finish that study. They can also retain identifiable materials already used for research integrity purposes, such as verifying results. But no new data collection should occur after withdrawal, and your existing identifiable materials cannot be used for any new research projects.
One complication that consent forms are supposed to disclose: once your identifiable information or samples have been shared with outside institutions or research teams, it may be difficult or impossible to recall them or prevent their future use. This is a real limitation that participants should understand before signing.
The Ethical Tension
Broad consent sits at the intersection of two competing values. On one side is research utility: the ability to answer as many scientific questions as possible using samples and data that people have voluntarily shared. On the other is individual autonomy: your right to control how your personal health information gets used.
Critics argue that broad consent tips the balance too far toward researchers. A tiered consent model, where you can choose which types of research you’re comfortable with and opt out of others, gives you more granular control. As one analysis in BMJ Global Health put it, “tiered consent provides individuals with the autonomy to participate in a study at a risk level with which they are comfortable, whereas broad consent demands exposure to maximum risk in order to participate.” In other words, broad consent is binary: you’re either in for everything or out entirely.
Supporters counter that tiered consent creates its own problems. It’s harder to explain, harder to store electronically, and harder to query when researchers are assembling datasets. Translation into multiple languages adds further complexity. From a logistical standpoint, broad consent keeps large-scale research feasible.
Commercial Data Use and Privacy Gaps
The rise of mobile health apps and wearable devices has introduced a new wrinkle. When research involves commercial technology, participants often must agree to the company’s terms of use in addition to any research consent form. Those commercial terms frequently include lengthy legal language that may permit the release or sale of personally identifiable data, a significant departure from the privacy protections built into research consent.
This creates an awkward situation. Researchers may need participants to accept commercial terms of use as a condition of joining a study, effectively exposing them to risks that the research consent process was never designed to address. The volume of health data shared or sold by technology companies, and the lack of transparency around these practices, has fueled growing public unease. The protections that apply to data collected under broad consent in a regulated research setting do not automatically extend to data flowing through commercial platforms.
What a Broad Consent Form Should Tell You
A well-constructed broad consent form should give you enough information to make a meaningful choice, even though the specific future studies are unknown. You should expect to see a description of the types of research that might be conducted, how long your samples or data will be stored, whether commercial profit could result from the research, and whether you’ll be informed of results from individual studies. The form should also clearly spell out what happens if you withdraw consent, including the limitations on recalling materials already distributed to other institutions.
Because the future uses are inherently vague, the quality of the consent form matters enormously. A form that buries key details in dense legal language undermines the whole purpose of asking permission in the first place. The best broad consent documents are written in plain language, acknowledge what is and isn’t known about future research plans, and are honest about the trade-offs involved.